Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

New Study Highlights Biopharma’s Current and Future Growth Drivers

Issue: July 26, 2016
| Category: Merck Topics


Manufacturers in today’s biopharma industry are facing unprecedented challenges as they enter unfamiliar geographies, aggressively replenish pipelines and expand into novel areas requiring more complex development and production.

We recently sponsored a study that was conducted by the Economist Intelligence Unit (EIU), in which 254 global biopharmaceutical executives were asked how their companies will manage new risks associated with the changing biopharma landscape.

This study, detailed in The Changing Biopharma Risk Equation, examines how new growth strategies are creating exposure to different types of risk and explores options for successfully navigating this unexplored territory.

To download the report, access additional content on the changing nature of biopharma and explore how we can help companies overcome these challenges, click here for more information.

In This Same Issue

Recent Articles

Article Search

Article Archives

Events

Webinars